‌

US Patent 8778345 Anti-CD40 antibodies

Patent 8778345 was granted and assigned to Apexigen on July, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Apexigen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87783450

Patent Inventor Names

Guo-Liang Yu0

Yongke Zhang0

Weimin Zhu0

Date of Patent

July 15, 2014

Patent Application Number

134587300

Date Filed

April 27, 2012

Patent Citations Received

‌

US Patent 11780912 Composition for prophylaxis or treatment of IL-8 related diseases

Patent Primary Examiner

‌

Phillip Gambel

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8778345 Anti-CD40 antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API